Multimorbidity in type 1 Gaucher disease patients under miglustat therapy

被引：0

作者：

Engay, Blanca Medrano ^{[1
]}

Roy, Ana ^{[2
]}

Atutxa, Koldo ^{[3
]}

Diaz-Morant, Vicente ^{[4
]}

Garcia-Frade, Javier ^{[5
]}

Hernandez-Martin, Roberto ^{[6
]}

Luno, Elisa ^{[7
]}

Noya, Soledad ^{[8
]}

de la Serna, Javier ^{[9
]}

Villalon, Lucia ^{[10
]}

Giraldo, Pilar ^{[11
]}

机构：

[1] Inst Invest Sanitaria Aragon, Zaragoza, Spain

[2] Fdn Espanola Estudio & Terapeut Enfermedad Gauche, Zaragoza, Spain

[3] Hosp Galdakao, Bilbao, Spain

[4] Hosp Serrania Ronda, Ronda, Spain

[5] Hosp Rio Hortega, Valladolid, Spain

[6] Hosp Virgen de la Concha, Zamora, Spain

[7] Hosp Univ Cent Asturias, Oviedo, Spain

[8] Hosp Teresa Herrera, La Coruna, Spain

[9] Hosp Univ Doce Octubre, Madrid, Spain

[10] Hosp Alcorcon, Madrid, Spain

[11] Ciber Enfermedades Raras, Zaragoza, Spain

来源：

MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2017.12.245

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

236

引用

页码：S93 / S94

页数：2

共 50 条

[1] Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1
Pastores, GM
Barnett, NL
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 273 - 281
[2] Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy
Puzo, J.
Alfonso, P.
Irun, P.
Gervas, J.
Pocovi, M.
Giraldo, P.
ATHEROSCLEROSIS, 2010, 209 (02) : 515 - 519
[3] Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy
Canda, Ebru
Kose, Melis
Kagnici, Mehtap
Ucar, Sema Kalkan
Sozmen, Eser Y.
Coker, Mahmut
BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 180 - 184
[4] Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
Weinreb, NJ
Barranger, JA
Charrow, J
Grabowski, GA
Mankin, HJ
Mistry, P
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) : 223 - 229
[5] Long term efficacy and safety of miglustat therapy in type 1 Gaucher disease
Giraldo, M.
Latre, P.
Acedo, A.
Alonso, D.
Barez, A.
Martin, A.
Franco, R.
Fernandez-Villamor, A.
Pocovi, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 279 - 279
[6] Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: Two case reports
Amato D.
Patterson M.A.
Journal of Medical Case Reports, 12 (1)
[7] Treatment by miglustat of an elderly patient with Gaucher's disease type 1
de Roux-Serratrice, Christine
Serratrice, Jacques
Disdier, Patrick
Weiller, Pierre-Jean
PRESSE MEDICALE, 2006, 35 : S30 - S32
[8] Treat type I Gaucher disease with miglustat - Experience with two patients
Yang, Sandra
Tifft, Cynthia
MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S22 - S22
[9] Goal-oriented therapy with miglustat in Gaucher disease
Pastores, Gregory M.
Giraldo, Pilar
Cherin, Patrick
Mehta, Atul
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 23 - 37
[10] Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study
Kuter, David J.
Mehta, Atul
Hollak, Carla E. M.
Giraldo, Pilar
Hughes, Derralynn
Belmatoug, Nadia
Brand, Monika
Muller, Audrey
Schaaf, Berthold
Giorgino, Ruben
Zimran, Ari
BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (02) : 116 - 124

← 1 2 3 4 5 →